RxDoctor Payments Data

Richard Aguilar

Internal Medicine · Miami, FLNPI 1528024056

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $177,024 of the $239,027 with a category attached, or 74.1%. Novo Nordisk accounts for 64.0% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $119,100 and has fallen 99.7% since, to $313 in 2025. Among internal medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$239,027in general payments, 2019–2025

Across 282 payments — averaging $847.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$153K
  • Lilly USA, LLC$45K
  • Johnson & Johnson$33K
  • Genentech, Inc.$4K
  • Regeneron Healthcare Solutions, Inc.$2K
  • Merck$1K
  • plus $489 from 7 others

What the payments were for

  • Consulting fees$25,56911%
  • Speaking & faculty fees$177,02474%
  • Travel & lodging$29,88213%
  • Food & beverage$6,5523%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$239,027 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida →

Other internal medicine in Miami

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →